Genetic Modification Of Human Research Articles

SOME ASPECTS OF THE APPLICATION OF NEW MEDICAL TECHNOLOGIES IN REPRODUCTION, THERAPY AND GENETIC MODIFICATION OF HUMANS, PLANTS AND ANIMALS THROUGH THE PRISM OF INTELLECTUAL PROPERTY RIGHTS PROTECTION IN SOUTH AFRICA

This article aims to demonstrates some facets of the current state of legal regulation and ethical problems of application of new medical technologies in reproduction, therapy and genetic modification of humans, plants and animals through the prism of intellectual property rights protection and based on: the materials of a number of normative acts (laws, ministerial Regulations) of one of the BRICS countries - South Africe. In this format, based on analytical reflections over information taken from sources and literature from the list of sources and literature, as well as a number of legal provisions driven to life by the existence and application of such technologies and new knowledge; opinions, ideas and ethical and legal discussions, the article analyzes the provisions of South Africa's approaches that create patterns of application of new medical technologies, the potential and ethical and legal basis for such development, taking into account the current views of the doctrine and legislation. The relevance of this research is due to the fact that a number of approaches to legislation and ethical approaches under study are new and could not be considered in studies of an earlier period. Thus, this study serves to fill this gap. The author's results are presented in the light of the identified state interest within the framework of the liberal model of the relationship between law and bioethics in delineating the boundaries of permissible (notpermissible) use of new medical technologies in the field of reproduction and treatment of human, genetic modification of humans, animals and plants not only from the perspective of legal and ethical constraints, permissions and prohibitions but the implementation of the provisions of applicable South African legislation on the intellectual property rights protection, which, due to its examination request system, can not guarantee that the patented product - the result of genetic modification - can be freely used in South Africa with regard to the restrictions and prohibitions established by 2003 Act and relevant Regulations No. 175, 177, 180. The theoretical and practical significance of the results obtained is determined by the fact that Russian readers will be provided with up-to-date scientific information about the state of Indian legislation and doctrine, and other ideas in the field under study, which in practical terms will contribute to understanding the gap (or lack thereof) in the achievements in this field of Russian and foreign researchers and practitioners in terms of their implications at the level of practice and legislation.

Necessity or Vanity: Designer Babies, CRISPR, and the Future of Genetic Modifications

CRISPR technology can drastically speed up the pace of genetic experimentation and could possibly eliminate many hereditary diseases from bloodlines. CRISPR was discovered only by chance in microbes; experimenters eventually managed to apply the technique to mammalian genes. However, CRISPR is still very much underdeveloped, as in many areas it lacks in precision and efficiency. For humans, the main application of CRISPR is to eliminate hereditary disease, but it has also stimulated the urge for the bête noire of creating genetically modified children, called designer babies. The idea of designer babies is controversial, as to some, the genetic modification of humans is ethically very troubling. The majority of scientists believe that there needs to be a moratorium on the generation of genetically modified babies, but there are a select few with the exact opposite view. The majority of scientists insist that we cannot stop the advancement of contemporary technology and must go full force ahead. This paper attempts to trace the emergence of CRISPR and its potential utility for addressing human disease alongside its deficiencies and the ethical problems of designer babies. Lastly, recommendations are made to expedite CRISPR related future research and utilizing the technology for the benefit of generations to come.

Privacy, Liberty, and the Genetic Modification of Humans

In this paper I will argue that intangible property of this sort can be owned-that the proper subjects of intangible property claims include medical records, genetic profiles, and gene enhancement techniques. Coupled with a right to privacy, these intangible property rights allow individuals a wne of control that will, in most cases. justifiably exclude governmental or societal invasions into private domains. I will argue that the threshold for overriding privacy rights and intangible property rights is higher, in relation to genetic enhancement techniques and sensitive personal information, than is commonly suggested. Once the bar is raised, so-to-speak, the burden of overriding it is formidable. In the end, I am not so worried about the prospects of a brave new world brought upon us by gene manipulation-I am much more worried when societies, committees, and concerned citizens use the force of government to tell us what we can do to and in our own bodies.

Privacy, Liberty, Property, and the Genetic Modification of Humans

Can one's genetic profile be owned? How about techniques to improve genetic profiles? A brave new world of genetic enhancement is upon us and we'd better be ready to answer such questions. Adam Moore is ready. He thinks the answers to these questions are resoundingly "yes." He defends this on the ground of individual liberty in the face of potential government control of such technology. He argues that genetic property is to be assimilated to rights of privacy and property in general and can be owned. He defends this against several important objections on the basis of societal overriding needs or goods.